No Data
No Data
What Analysts Are Saying About DermTech Stock
DermTech (NASDAQ:DMTK) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below provides a concise overview of recent ratings by
Express News | Lake Street Downgrades DermTech to Hold, Announces $0.63 Price Target
DermTech Price Target Maintained With a $1.50/Share by Stephens & Co.
DermTech Price Target Maintained With a $1.50/Share by Stephens & Co.
Express News | Stephens & Co. Reiterates Equal-Weight on DermTech, Maintains $1.5 Price Target
Express News | DermTech Inc : Btig Cuts to Neutral From Buy: Btig Cuts to Neutral From Buy
DermTech Cut to Neutral From Buy by BTIG
DermTech Cut to Neutral From Buy by BTIG